Liping Liu, founder, CEO & CSO of HighTide Therapeutics invited to present at the HKEX Biotech Week 2019 conference, 28-30 May in Hong Kong. Dr. Liu presented HighTide Therapeutics in the “Deep Dive Workshop” on Day 3.
June 02, 2019
Learn More
Liping Liu invited to present at the 2019 Forum on Discovery & Development of NASH Drugs
May 28, 2019
Learn More
HighTide Therapeutics, today announced that it has been invited to deliver two presentation at Phar-East 2019, to be held March 18–20 in Singapore.
May 11, 2019
Learn More
Emerging Company Profile: Fatty liver disease has been a hot development area that keeps getting more attention, and one Chinese startup backed by the world’s largest heparin manufacturer is looking to launch a new therapy globally.
April 24, 2019
Learn More
Jeffrey Dao, Operations & Business Development Officer to present HighTide’s HTD1801 for primary sclerosing cholangitis (PSC) at the World Orphan Drug Congress USA 2019 in Oxon Hill, MD...
April 04, 2019
Learn More
[Rockville, Maryland, Dec. 11, 2018] — HighTide Therapeutics, today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9.
December 11, 2018
Learn More
We will contact you as soon as possible
© 2024 HighTide Therapeutics, Inc.